John Bateman has more than 25 years of experience litigating patent disputes, including serving as lead counsel at trial and on appeal. He focuses on life sciences, with a particular emphasis on representing generic drugmakers in disputes involving the Hatch-Waxman Act. He prides himself on partnering with clients to understand their business goals and then shape their legal strategy accordingly.
John has represented a wide variety of generic pharmaceutical clients, including companies based in the United States, India, Europe, and Israel. At trial, John has obtained judgments that patents asserted against his clients were not infringed, invalid, and/or unenforceable, clearing the way for them to bring their products to market. In other cases, John has helped develop strong positions on the merits at an early stage, including by initiating inter partes review proceedings, leading directly to the negotiation of favorable settlements.
Besides his life sciences practice, John has litigated disputes involving a broad range of other products, including GPS devices, plastic encapsulated integrated circuits, electrical connectors, egg sorting machines, gasoline pumps, and drapery hooks. He has significant experience with patent jury trials and has litigated patent cases in district courts throughout the country, particularly in Delaware and New Jersey.
In addition, John provides clients with opinions on infringement and validity issues regarding generic pharmaceutical products. His years of experience with Hatch-Waxman cases help him develop arguments that are more likely to prevail should they eventually go to trial. He also prepares and prosecutes patent applications in various technologies, especially for individual inventors.